Antonarakis, E. S., Tagawa, S. T., Galletti, G., Worroll, D., Ballman, K., Vanhuyse, M., . . . Giannakakou, P. (2017). Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer. J Clin Oncol.
Chicago Stili AlıntıAntonarakis, Emmanuel S., et al. "Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer." J Clin Oncol 2017.
MLA AlıntıAntonarakis, Emmanuel S., et al. "Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer." J Clin Oncol 2017.